OBJECTIVE: To probe into the effects of carbazochrome tablets on hemostasis and swelling reduction after hip replacement. METHODS: Totally 132 patients undergoing hip replacement admitted into this hospital from Jan. 2020 to Jan. 2021 were extracted to be the control group and the carbazochrome tablets group via the random number table

with 66 cases in each group. The control group was treated with thrombin freeze-dried powder after hip replacement

while the carbazochrome tablets group received carbazochrome tablets after hip replacement. Blood loss

blood transfusion

D-dimer

hemoglobin level

swelling

pain and postoperative adverse events were observed in two groups. RESULTS: Compared with the control group

the postoperative blood loss and blood transfusion rate of the carbazochrome tablets were lower

the difference was statistically significant（P<0.05）. Compared with the control group

D-dimer level decreased significantly and hemoglobin level increased significantly in the carbazochrome tablets group after surgery of 1

7 and 14 d

with statistically significant difference（P<0.05）. Compared with the control group

the degree of swelling was lighter and the pain score was lower in the carbazochrome tablets group

the differences were statistically significant（P<0.05）. Compared with the control group[22.73%（15/66）]

the incidence of postoperative adverse events in the carbazochrome tablets group was lower[6.06%（4/66）]

the difference was statistically significant（P<0.05）. CONCLUSIONS: The application of carbazochrome tablets after hip replacement is ideal for hemostasis and swelling reduction

which can reduce the amount of blood loss in patients

relieve the swelling in the affected limb and reduce the occurrence of adverse events.